Literature DB >> 31858231

Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.

Yusuke Kurita1,2, Kazuo Hara3, Takamichi Kuwahara1, Nobumasa Mizuno1, Nozomi Okuno1, Shin Haba1, Masataka Okuno4, Seiji Natsume4, Yoshiki Senda4, Kensuke Kubota2, Atsushi Nakajima2, Yasumasa Niwa5, Yasuhiro Shimizu4.   

Abstract

BACKGROUND: The treatment of small (≤ 2 cm), sporadic localized non-functional pancreatic neuroendocrine neoplasms (PNENs) is often controversial. This study aimed to investigate the clinical outcomes with observation and surgical resection in small PNENs.
METHODS: Seventy-five patients with small localized sporadic non-functional PNENs ≤ 2 cm, who underwent observation or surgical resection, were retrospectively reviewed. Changes in tumor size during follow-up in the observation group were also investigated.
RESULTS: The median age of the cohort was 61 (range 35-81) years. The tumor grades were G1, G2, and unknown, in 61 (81.3%), 8 (10.7%), and 6 (8.0%) patients, respectively. The mean follow-up periods in the observation (n = 23) and surgical resection groups (n = 52) were 52.3 (range 6.8-133.3) months and 73.0 (range 9.1-179.9) months, respectively. The median overall survival was not reached. During follow-up, no patient died of PNENs, two died of other diseases, three had lymph node metastases, and one experienced recurrence after surgical resection. There was no significant difference in overall survival between the observation and surgical resection groups (hazard ratio: 0.031, P = 0.417). The mean change in tumor size in the observation group was + 0.30 mm (range - 1.6 to + 3.0 mm). No deaths, tumor progression, lymph node metastases, distant metastases, or recurrence were noted in patients with PNENs ≤ 1 cm (n = 36).
CONCLUSIONS: The prognosis of small localized PNENs is good. Observation may be an alternative to surgery in high-risk patients and those with small G1 tumors, particularly those measuring ≤ 1 cm.

Entities:  

Keywords:  Observation; Pancreatic neuroendocrine neoplasms; Small tumors; Surgery

Year:  2019        PMID: 31858231     DOI: 10.1007/s00535-019-01655-w

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  27 in total

1.  Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading.

Authors:  Cecilia Piani; Giulia M Franchi; Chiara Cappelletti; Marina Scavini; Luca Albarello; Alessandro Zerbi; Paolo Giorgio Arcidiacono; Emanuele Bosi; Marco F Manzoni
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

2.  Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Sébastien Gaujoux; Stefano Partelli; Frédérique Maire; Mirko D'Onofrio; Béatrice Larroque; Domenico Tamburrino; Alain Sauvanet; Massimo Falconi; Philippe Ruszniewski
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

3.  Usefulness of endoscopic ultrasonography-elastography as a predictive tool for the occurrence of pancreatic fistula after pancreatoduodenectomy.

Authors:  Takamichi Kuwahara; Yoshiki Hirooka; Hiroki Kawashima; Eizaburo Ohno; Yukihiro Yokoyama; Tsutomu Fujii; Shigeo Nakamura; Yasuhiro Kodera; Masato Nagino; Hidemi Goto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-11-18       Impact factor: 7.027

4.  A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.

Authors:  Bo Liu; Atsushi Kudo; Yuko Kinowaki; Toshiro Ogura; Kosuke Ogawa; Hiroaki Ono; Yusuke Mitsunori; Daisuke Ban; Shinji Tanaka; Takumi Akashi; Minoru Tanabe
Journal:  J Gastroenterol       Date:  2019-03-12       Impact factor: 7.527

5.  Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.

Authors:  Kosuke Tsutsumi; Takao Ohtsuka; Yasuhisa Mori; Minoru Fujino; Takaharu Yasui; Shinichi Aishima; Shunichi Takahata; Masafumi Nakamura; Tetsuhide Ito; Masao Tanaka
Journal:  J Gastroenterol       Date:  2012-02-17       Impact factor: 7.527

6.  Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes.

Authors:  Asima Cheema; Jill Weber; Jonathan R Strosberg
Journal:  Ann Surg Oncol       Date:  2012-02-14       Impact factor: 5.344

7.  Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience.

Authors:  Shin Haba; Kenji Yamao; Vikram Bhatia; Nobumasa Mizuno; Kazuo Hara; Susumu Hijioka; Hiroshi Imaoka; Yasumasa Niwa; Masahiro Tajika; Shinya Kondo; Tsutomu Tanaka; Yasuhiro Shimizu; Yasushi Yatabe; Waki Hosoda; Hiroshi Kawakami; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2012-10-24       Impact factor: 7.527

8.  Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.

Authors:  Toshiyuki Hasegawa; Kenji Yamao; Susumu Hijioka; Vikram Bhatia; Nobumasa Mizuno; Kazuo Hara; Hiroshi Imaoka; Yasumasa Niwa; Masahiro Tajika; Shinya Kondo; Tutomu Tanaka; Yasuhiro Shimizu; Taira Kinoshita; Takuhiro Kohsaki; Isao Nishimori; Shinji Iwasaki; Toshiji Saibara; Waki Hosoda; Yasushi Yatabe
Journal:  Endoscopy       Date:  2013-11-11       Impact factor: 10.093

Review 9.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

10.  Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.

Authors:  Louis C Lee; Clive S Grant; Diva R Salomao; Joel G Fletcher; Naoki Takahashi; Jeff L Fidler; Michael J Levy; Marianne Huebner
Journal:  Surgery       Date:  2012-10-24       Impact factor: 3.982

View more
  7 in total

1.  The Landmark Series: Pancreatic Neuroendocrine Tumors.

Authors:  Jordan M Cloyd; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2020-09-18       Impact factor: 5.344

2.  A New Preoperative Scoring System for Predicting Aggressiveness of Non-Functioning Pancreatic Neuroendocrine Neoplasms.

Authors:  Tetsuya Takikawa; Kazuhiro Kikuta; Shin Hamada; Kiyoshi Kume; Shin Miura; Naoki Yoshida; Yu Tanaka; Ryotaro Matsumoto; Mio Ikeda; Fumiya Kataoka; Akira Sasaki; Hidehiro Hayashi; Waku Hatta; Yohei Ogata; Kei Nakagawa; Michiaki Unno; Atsushi Masamune
Journal:  Diagnostics (Basel)       Date:  2022-02-03

3.  Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.

Authors:  Xi Liu; Wenjie Chin; Chenggeng Pan; Weichen Zhang; Jun Yu; Shusen Zheng; Yuanxing Liu
Journal:  Gland Surg       Date:  2021-01

4.  Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors.

Authors:  Estela Regina Ramos Figueira; Julia Fray Ribeiro; Thiago Costa Ribeiro; Ricardo Jureidini; Guilherme Naccache Namur; Thiago Nogueira Costa; Telesforo Bacchella; Ivan Cecconello
Journal:  Gastroenterol Res Pract       Date:  2021-04-24       Impact factor: 2.260

5.  Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.

Authors:  Zheng Zhang; Fei Wang; Zheng Li; Zeng Ye; Qifeng Zhuo; Wenyan Xu; Wensheng Liu; Mengqi Liu; Guixiong Fan; Yi Qin; Yue Zhang; Xuemin Chen; Xianjun Yu; Xiaowu Xu; Shunrong Ji
Journal:  BMC Surg       Date:  2022-05-10       Impact factor: 2.102

6.  Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.

Authors:  Qingquan Tan; Xing Wang; Yichen Li; Yingyi Liu; Xubao Liu; Nengwen Ke
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-06       Impact factor: 6.055

7.  Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram.

Authors:  Shengnan Zhou; Shitao Jiang; Weijie Chen; Haixin Yin; Liangbo Dong; Hao Zhao; Shaoqi Han; Xiaodong He
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.